Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-25T04:13:54.107Z Has data issue: false hasContentIssue false
  • English
  • Français

Neurocognitive Effects of HIV, Hepatitis C, and Substance Use History

Published online by Cambridge University Press:  02 December 2011

Kathryn N. Devlin ,
Assawin Gongvatana ,
Uraina S. Clark ,
Jesse D. Chasman ,
Michelle L. Westbrook ,
Karen T. Tashima ,
Bradford Navia  and
Ronald A. Cohen
Kathryn N. Devlin
Affiliation:
Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island
Assawin Gongvatana
Affiliation:
Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
Uraina S. Clark
Affiliation:
Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
Jesse D. Chasman
Affiliation:
Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
Michelle L. Westbrook
Affiliation:
Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island Center for AIDS Research, The Miriam Hospital, Providence, Rhode Island
Karen T. Tashima
Affiliation:
Center for AIDS Research, The Miriam Hospital, Providence, Rhode Island Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
Bradford Navia
Affiliation:
Tufts University School of Medicine, Boston, Massachusetts
Ronald A. Cohen*
Affiliation:
Centers for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University, Providence, Rhode Island
*
Correspondence and reprint requests to: Ronald A. Cohen, Centers for Behavioral & Preventive Medicine, Coro Building, Suite 314, One Hoppin Street, Providence, RI 02903. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

HIV-associated neurocognitive dysfunction persists in the highly active antiretroviral therapy (HAART) era and may be exacerbated by comorbidities, including substance use and hepatitis C virus (HCV) infection. However, the neurocognitive impact of HIV, HCV, and substance use in the HAART era is still not well understood. In the current study, 115 HIV-infected and 72 HIV-seronegative individuals with significant rates of lifetime substance dependence and HCV infection received comprehensive neuropsychological assessment. We examined the effects of HIV serostatus, HCV infection, and substance use history on neurocognitive functioning. We also examined relationships between HIV disease measures (current and nadir CD4, HIV RNA, duration of infection) and cognitive functioning. Approximately half of HIV-infected participants exhibited neurocognitive impairment. Detectable HIV RNA but not HIV serostatus was significantly associated with cognitive functioning. HCV was among the factors most consistently associated with poorer neurocognitive performance across domains, while substance use was less strongly associated with cognitive performance. The results suggest that neurocognitive impairment continues to occur in HIV-infected individuals in association with poor virologic control and comorbid conditions, particularly HCV coinfection. (JINS, 2012, 18, 68–78)

Keywords

NeuropsychologyHIV-1Chronic hepatitis CViral loadCocaine dependenceOpiate dependence
Type
Research Articles
Information
Journal of the International Neuropsychological Society , Volume 18 , Issue 1 , January 2012 , pp. 68 - 78
Copyright
Copyright © The International Neuropsychological Society 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ances, B.M., Vaida, F., Yeh, M.J., Liang, C.L., Buxton, R.B., Letendre, S., Ellis, R.J. (2010). HIV infection and aging independently affect brain function as measured by functional magnetic resonance imaging. Journal of Infectious Diseases, 201(3), 336–340.CrossRefGoogle ScholarPubMed
Armstrong, G.L., Wasley, A., Simard, E.P., McQuillan, G.M., Kuhnert, W.L., Alter, M.J. (2006). The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of Internal Medicine, 144(10), 705–714.CrossRefGoogle ScholarPubMed
Bajaj, J.S., Wade, J.B., Sanyal, A.J. (2009). Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology, 50(6), 2014–2021.CrossRefGoogle ScholarPubMed
Basso, M.R., Bornstein, R.A. (2000). Neurobehavioural consequences of substance abuse and HIV infection. Journal of Psychopharmacology, 14(3), 228–237.CrossRefGoogle ScholarPubMed
Benedict, R.H.B. (1997). Brief Visuospatial Memory Test - Revised. Odessa, FL: Psychological Assessment Resources.Google Scholar
Benedict, R.H.B., Schretlen, A., Groninger, L., Brandt, J. (1998). Hopkins Verbal Learning Test Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12, 43–55.CrossRefGoogle Scholar
Benedict, R.H.B., Schretlen, D., Groninger, L., Dobraski, M., Shpritz, B. (1996). Revision of the Brief Visuospatial Memory Test: Studies of normal performance, reliability, and validity. Psychological Assessment, 8(2), 145–153.CrossRefGoogle Scholar
Benton, A.L., Hamsher, K., Sivan, A.B. (1994). Multilingual Aphasia Examination. Iowa City: AJA Associates.Google Scholar
Bica, I., McGovern, B., Dhar, R., Stone, D., McGowan, K., Scheib, R., Snydman, D.R. (2001). Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 32(3), 492–497.CrossRefGoogle ScholarPubMed
Bornstein, R.A., Nasrallah, H.A., Para, M.F., Whitacre, C.C., Fass, R.J. (1994). Duration of illness and neuropsychological performance in asymptomatic HIV infection. Journal of Neuropsychiatry and Clinical Neurosciences, 6(2), 160–164.Google Scholar
Brandt, J., Benedict, R.H.B. (1991). Hopkins Verbal Learning Test-Revised (HVLT-R). Lutz, FL: Psychological Assessment Resources, Inc.Google Scholar
Brew, B.J. (2004). Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS, 18(Suppl. 1), S75–S78.CrossRefGoogle ScholarPubMed
Brew, B.J., Crowe, S.M., Landay, A., Cysique, L.A., Guillemin, G. (2009). Neurodegeneration and ageing in the HAART era. Journal of Neuroimmune Pharmacology, 4(2), 163–174.CrossRefGoogle ScholarPubMed
Brown, T.T., Cole, S.R., Li, X., Kingsley, L.A., Palella, F.J., Riddler, S.A., Dobs, A.S. (2005). Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine, 165(10), 1179–1184.Google Scholar
Carey, C.L., Woods, S.P., Gonzalez, R., Conover, E., Marcotte, T.D., Grant, I., Heaton, R.K. (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26(3), 307–319.CrossRefGoogle ScholarPubMed
Carrat, F., Bani-Sadr, F., Pol, S., Rosenthal, E., Lunel-Fabiani, F., Benzekri, A., Perronne, C. (2004). Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial. JAMA, 292(23), 2839–2848.Google Scholar
Chang, L., Ernst, T., Witt, M.D., Ames, N., Gaiefsky, M., Miller, E. (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage, 17(3), 1638–1648.Google Scholar
Chen, Y., An, H., Zhu, H., Stone, T., Smith, J.K., Hall, C., Lin, W. (2009). White matter abnormalities revealed by diffusion tensor imaging in non-demented and demented HIV+ patients. Neuroimage, 47(4), 1154–1162.Google Scholar
Cherner, M., Ellis, R.J., Lazzaretto, D., Young, C., Mindt, M.R., Atkinson, J.H., Heaton, R.K. (2004). Effects of HIV-1 infection and aging on neurobehavioral functioning: Preliminary findings. AIDS, 18(Suppl. 1), S27–S34.CrossRefGoogle ScholarPubMed
Cherner, M., Letendre, S., Heaton, R.K., Durelle, J., Marquie-Beck, J., Gragg, B., Grant, I. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64(8), 1343–1347.CrossRefGoogle ScholarPubMed
Childs, E.A., Lyles, R.H., Selnes, O.A., Chen, B., Miller, E.N., Cohen, B.A., McArthur, J.C. (1999). Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology, 52(3), 607–613.CrossRefGoogle ScholarPubMed
Chung, R.T., Andersen, J., Volberding, P., Robbins, G.K., Liu, T., Sherman, K.E., van der Horst, C. (2004). Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. New England Journal of Medicine, 351(5), 451–459.Google Scholar
Clifford, D.B. (2008). HIV-associated neurocognitive disease continues in the antiretroviral era. Topics in HIV Medicine, 16(2), 94–98.Google ScholarPubMed
Clifford, D.B., Evans, S.R., Yang, Y., Gulick, R.M. (2005). The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects. AIDS, 19(Suppl. 3), S64–S71.Google Scholar
Clifford, D.B., Smurzynski, M., Park, L.S., Yeh, T.M., Zhao, Y., Blair, L., Evans, S.R. (2009). Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology, 73(4), 309–314.CrossRefGoogle ScholarPubMed
Cohen, R.A., Boland, R., Paul, R., Tashima, K.T., Schoenbaum, E.E., Celentano, D.D., Carpenter, C.C. (2001). Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS, 15(3), 341–345.CrossRefGoogle ScholarPubMed
Cohen, R.A., de la Monte, S., Gongvatana, A., Ombao, H., Gonzalez, B., Devlin, K.N., Tashima, K.T. (2011). Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning. Journal of Neuroimmunology, 233(1–2), 204–210.Google Scholar
Cohen, R.A., Harezlak, J., Gongvatana, A., Buchthal, S., Schifitto, G., Clark, U., Navia, B. (2010). Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes. Journal of Neurovirology, 16(6), 435–444.Google Scholar
Cohen, R.A., Harezlak, J., Schifitto, G., Hana, G., Clark, U., Gongvatana, A., Navia, B. (2010). Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era. Journal of Neurovirology, 16(1), 25–32.CrossRefGoogle ScholarPubMed
Compton, W.M., Thomas, Y.F., Stinson, F.S., Grant, B.F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566–576.CrossRefGoogle ScholarPubMed
Crum, N.F., Riffenburgh, R.H., Wegner, S., Agan, B.K., Tasker, S.A., Spooner, K.M., Wallace, M.R. (2006). Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. Journal of Acquired Immune Deficiency Syndromes, 41(2), 194–200.CrossRefGoogle ScholarPubMed
Cysique, L.A., Maruff, P., Brew, B.J. (2006). Variable benefit in neuropsychological function in HIV-infected HAART-treated patients. Neurology, 66(9), 1447–1450.Google Scholar
Cysique, L.A., Vaida, F., Letendre, S., Gibson, S., Cherner, M., Woods, S.P., Ellis, R.J. (2009). Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy. Neurology, 73(5), 342–348.CrossRefGoogle ScholarPubMed
Davis, P.E., Liddiard, H., McMillan, T.M. (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, 67(1), 105–108.CrossRefGoogle ScholarPubMed
de la Monte, S.M., Longato, L., Tong, M., DeNucci, S., Wands, J.R. (2009). The liver-brain axis of alcohol-mediated neurodegeneration: Role of toxic lipids. International Journal of Environmental Research and Public Health, 6(7), 2055–2075.CrossRefGoogle ScholarPubMed
de la Monte, S.M., Tong, M., Nguyen, V., Setshedi, M., Longato, L., Wands, J.R. (2010). Ceramide-mediated insulin resistance and impairment of cognitive-motor functions. Journal of Alzheimer's Disease, 21(3), 967–984.CrossRefGoogle ScholarPubMed
Deeks, S.G., Phillips, A.N. (2009). HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ (Clinical Research Ed.), 338, a3172.CrossRefGoogle ScholarPubMed
Di Sclafani, V., Tolou-Shams, M., Price, L.J., Fein, G. (2002). Neuropsychological performance of individuals dependent on crack-cocaine, or crack-cocaine and alcohol, at 6 weeks and 6 months of abstinence. Drug and Alcohol Dependence, 66(2), 161–171.CrossRefGoogle ScholarPubMed
Eldreth, D.A., Matochik, J.A., Cadet, J.L., Bolla, K.I. (2004). Abnormal brain activity in prefrontal brain regions in abstinent marijuana users. Neuroimage, 23(3), 914–920.Google Scholar
Ellis, R., Langford, D., Masliah, E. (2007). HIV and antiretroviral therapy in the brain: Neuronal injury and repair. Nature Reviews. Neuroscience, 8(1), 33–44.Google Scholar
Ersche, K.D., Clark, L., London, M., Robbins, T.W., Sahakian, B.J. (2006). Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology, 31(5), 1036–1047.Google Scholar
Fals-Stewart, W., Schafer, J., Lucente, S., Rustine, T., Brown, L. (1994). Neurobehavioral consequences of prolonged alcohol and substance abuse: A review of findings and treatment implications. Clinical Psychology Review, 14(8), 755–778.Google Scholar
Fein, G., Torres, J., Price, L.J., Di Sclafani, V. (2006). Cognitive performance in long-term abstinent alcoholic individuals. Alcoholism, Clinical and Experimental Research, 30(9), 1538–1544.Google Scholar
Fernandez-Serrano, M.J., Perez-Garcia, M., Schmidt Rio-Valle, J., Verdejo-Garcia, A. (2010). Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. Journal of Psychopharmacology, 24(9), 1317–1332.Google Scholar
Fernandez-Serrano, M.J., Perez-Garcia, M., Verdejo-Garcia, A. (2011). What are the specific vs. generalized effects of drugs of abuse on neuropsychological performance? Neuroscience and Biobehavioral Reviews, 35(3), 377–406.CrossRefGoogle ScholarPubMed
Forton, D.M., Allsop, J.M., Cox, I.J., Hamilton, G., Wesnes, K., Thomas, H.C., Taylor-Robinson, S.D. (2005). A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection. AIDS, 19(Suppl. 3), S53–S63.Google Scholar
Forton, D.M., Allsop, J.M., Main, J., Foster, G.R., Thomas, H.C., Taylor-Robinson, S.D. (2001). Evidence for a cerebral effect of the hepatitis C virus. Lancet, 358(9275), 38–39.CrossRefGoogle ScholarPubMed
Forton, D.M., Thomas, H.C., Murphy, C.A., Allsop, J.M., Foster, G.R., Main, J., Taylor-Robinson, S.D. (2002). Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology, 35(2), 433–439.CrossRefGoogle Scholar
Golden, C.J. (1978). Stroop Color and Word Test. Chicago: Stoelting.Google Scholar
Gongvatana, A., Cohen, R.A., Correia, S., Devlin, K.N., Miles, J., Clark, U.S., Tashima, K.T. (2011, February). Impact of Hepatitis C and HIV coinfection on cerebral white matter integrity. Proceedings of the 39th Annual Meeting of the International Neuropsychological Society, Boston, MA.Google Scholar
Gongvatana, A., Schweinsburg, B.C., Taylor, M.J., Theilmann, R.J., Letendre, S.L., Alhassoon, O.M., Grant, I. (2009). White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. Journal of Neurovirology, 15(2), 187–195.CrossRefGoogle ScholarPubMed
Grant, B.F. (1996). Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: Results of the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse, 8(2), 195–210.Google Scholar
Green, J.E., Saveanu, R.V., Bornstein, R.A. (2004). The effect of previous alcohol abuse on cognitive function in HIV infection. American Journal of Psychiatry, 161(2), 249–254.Google Scholar
Gruber, S.A., Silveri, M.M., Yurgelun-Todd, D.A. (2007). Neuropsychological consequences of opiate use. Neuropsychology Review, 17(3), 299–315.Google Scholar
Harezlak, J., Buchthal, S., Taylor, M., Schifitto, G., Zhong, J., Daar, E., Navia, B. (2011). Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment. AIDS, 25(5), 625–633.Google Scholar
Hasin, D.S., Stinson, F.S., Ogburn, E., Grant, B.F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry, 64(7), 830–842.Google Scholar
Heaton, R.K., Clifford, D.B., Franklin, D.R. Jr., Woods, S.P., Ake, C., Vaida, F., Grant, I. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087–2096.CrossRefGoogle ScholarPubMed
Heaton, R.K., Grant, I., Butters, N., White, D.A., Kirson, D., Atkinson, J.H., … the HNRC Group. (1995). The HNRC 500—neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. Journal of the International Neuropsychological Society, 1(3), 231–251.Google Scholar
Heaton, R.K., Miller, W., Taylor, M., Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources.Google Scholar
Hesselink, J.R., Tien, R., Spoto, G., Jernigan, T.L., Grant, I. (1991, June). Accelerated brain atrophy and parenchymal change in patients with AIDS. Proceedings of the International Conference on AIDS, Florence, Italy.Google Scholar
Hilsabeck, R.C., Castellon, S.A., Hinkin, C.H. (2005). Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clinical Infectious Diseases, 41(Suppl. 1), S38–S44.Google Scholar
Hilsabeck, R.C., Perry, W., Hassanein, T.I. (2002). Neuropsychological impairment in patients with chronic hepatitis C. Hepatology, 35(2), 440–446.Google Scholar
Hinkin, C.H., Castellon, S.A., Levine, A.J., Barclay, T.R., Singer, E.J. (2008). Neurocognition in individuals co-infected with HIV and hepatitis C. Journal of Addictive Diseases, 27(2), 11–17.CrossRefGoogle ScholarPubMed
Janssen, R.S., Saykin, A.J., Cannon, L., Campbell, J., Pinsky, P.F., Hessol, N.A., Kaplan, J.E. (1989). Neurological and neuropsychological manifestations of HIV-1 infection: Association with AIDS-related complex but not asymptomatic HIV-1 infection. Annals of Neurology, 26(5), 592–600.Google Scholar
Jernigan, T.L., Archibald, S., Hesselink, J.R., Atkinson, J.H., Velin, R.A., McCutchan, J.A., Grant, I. (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. The HNRC Group. Archives of Neurology, 50(3), 250–255.Google Scholar
Kellogg, S.H., McHugh, P.F., Bell, K., Schluger, J.H., Schluger, R.P., LaForge, K.S., Kreek, M.J. (2003). The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug and Alcohol Dependence, 69(2), 137–150.Google Scholar
Kim, W.R. (2002). The burden of hepatitis C in the United States. Hepatology, 36(5 Suppl. 1), S30–S34.Google ScholarPubMed
Kløve, H. (1963). Grooved pegboard. Lafayette, IN: Lafayette Instruments.Google Scholar
Kramer, L., Bauer, E., Funk, G., Hofer, H., Jessner, W., Steindl-Munda, P., Ferenci, P. (2002). Subclinical impairment of brain function in chronic hepatitis C infection. Journal of Hepatology, 37(3), 349–354.Google Scholar
Laskus, T., Radkowski, M., Bednarska, A., Wilkinson, J., Adair, D., Nowicki, M., Rakela, J. (2002). Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. Journal of Virology, 76(19), 10064–10068.Google Scholar
Letendre, S.L., McCutchan, J.A., Childers, M.E., Woods, S.P., Lazzaretto, D., Heaton, R.K., Ellis, R.J. (2004). Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Annals of Neurology, 56(3), 416–423.Google Scholar
Letendre, S.L., Paulino, A.D., Rockenstein, E., Adame, A., Crews, L., Cherner, M., Masliah, E. (2007). Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. Journal of Infectious Diseases, 196(3), 361–370.Google Scholar
Lundqvist, T. (2005). Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology, Biochemistry and Behavior, 81(2), 319–330.Google Scholar
Martin-Thormeyer, E.M., Paul, R.H. (2009). Drug abuse and hepatitis C infection as comorbid features of HIV associated neurocognitive disorder: Neurocognitive and neuroimaging features. Neuropsychology Review, 19(2), 215–231.CrossRefGoogle ScholarPubMed
McArthur, J.C. (2004). HIV dementia: An evolving disease. Journal of Neuroimmunology, 157(1–2), 3–10.Google Scholar
McArthur, J.C., McClernon, D.R., Cronin, M.F., Nance-Sproson, T.E., Saah, A.J., St Clair, M., Lanier, E.R. (1997). Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology, 42(5), 689–698.Google Scholar
McCrea, M., Cordoba, J., Vessey, G., Blei, A.T., Randolph, C. (1996). Neuropsychological characterization and detection of subclinical hepatic encephalopathy. Archives of Neurology, 53(8), 758–763.Google Scholar
McCutchan, J.A., Wu, J.W., Robertson, K., Koletar, S.L., Ellis, R.J., Cohn, S., Williams, P.L. (2007). HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS, 21(9), 1109–1117.Google Scholar
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., d'Arminio Monforte, A., Lundgren, J.D. (2003). Decline in the AIDS and death rates in the EuroSIDA study: An observational study. Lancet, 362(9377), 22–29.Google Scholar
Monga, H.K., Rodriguez-Barradas, M.C., Breaux, K., Khattak, K., Troisi, C.L., Velez, M., Yoffe, B. (2001). Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clinical Infectious Diseases, 33(2), 240–247.Google Scholar
Moore, D.J., Masliah, E., Rippeth, J.D., Gonzalez, R., Carey, C.L., Cherner, M., Grant, I. (2006). Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS, 20(6), 879–887.CrossRefGoogle ScholarPubMed
Morgello, S., Estanislao, L., Ryan, E., Gerits, P., Simpson, D., Verma, S., Sharp, V. (2005). Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals. AIDS, 19(Suppl. 3), S116–S122.Google Scholar
Nath, A., Maragos, W.F., Avison, M.J., Schmitt, F.A., Berger, J.R. (2001). Acceleration of HIV dementia with methamphetamine and cocaine. Journal of Neurovirology, 7(1), 66–71.Google Scholar
O'Malley, S., Adamse, M., Heaton, R.K., Gawin, F.H. (1992). Neuropsychological impairment in chronic cocaine abusers. American Journal of Drug and Alcohol Abuse, 18(2), 131–144.Google Scholar
Obel, N., Thomsen, H.F., Kronborg, G., Larsen, C.S., Hildebrandt, P.R., Sorensen, H.T., Gerstoft, J. (2007). Ischemic heart disease in HIV-infected and HIV-uninfected individuals: A population-based cohort study. Clinical Infectious Diseases, 44(12), 1625–1631.Google Scholar
Palella, F.J. Jr., Baker, R.K., Moorman, A.C., Chmiel, J.S., Wood, K.C., Brooks, J.T., Holmberg, S.D. (2006). Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study. Journal of Acquired Immune Deficiency Syndromes, 43(1), 27–34.CrossRefGoogle ScholarPubMed
Pascual-Leone, A., Dhuna, A., Anderson, D.C. (1991). Longterm neurological complications of chronic, habitual cocaine abuse. Neurotoxicology, 12(3), 393–400.Google Scholar
Paul, R.H., Ernst, T., Brickman, A.M., Yiannoutsos, C.T., Tate, D.F., Cohen, R.A., Navia, B.A. (2008). Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV. Journal of the International Neuropsychological Society, 14(5), 725–733.Google Scholar
Paul, R.H., Yiannoutsos, C.T., Miller, E.N., Chang, L., Marra, C.M., Schifitto, G., Navia, B.A. (2007). Proton MRS and neuropsychological correlates in AIDS dementia complex: Evidence of subcortical specificity. Journal of Neuropsychiatry and Clinical Neurosciences, 19(3), 283–292.Google Scholar
Perry, W., Hilsabeck, R.C., Hassanein, T.I. (2008). Cognitive dysfunction in chronic hepatitis C: A review. Digestive Diseases and Sciences, 53(2), 307–321.Google Scholar
Pezawas, L.M., Fischer, G., Diamant, K., Schneider, C., Schindler, S.D., Thurnher, M., Kasper, S. (1998). Cerebral CT findings in male opioid-dependent patients: Stereological, planimetric and linear measurements. Psychiatry Research, 83(3), 139–147.Google Scholar
Phillips, A.N., Neaton, J., Lundgren, J.D. (2008). The role of HIV in serious diseases other than AIDS. AIDS, 22(18), 2409–2418.CrossRefGoogle ScholarPubMed
Pomara, N., Crandall, D.T., Choi, S.J., Johnson, G., Lim, K.O. (2001). White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study. Psychiatry Research, 106(1), 15–24.Google Scholar
Powles, T., Robinson, D., Stebbing, J., Shamash, J., Nelson, M., Gazzard, B., Bower, M. (2009). Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. Journal of Clinical Oncology, 27(6), 884–890.Google Scholar
Radloff, L.S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.Google Scholar
Reitan, R.M. (1992). Trail Making Test. Tucson, AZ: Reitan Neuropsychology Laboratory.Google Scholar
Rippeth, J.D., Heaton, R.K., Carey, C.L., Marcotte, T.D., Moore, D.J., Gonzalez, R., Grant, I. (2004). Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Journal of the International Neuropsychological Society, 10(1), 1–14.Google Scholar
Robertson, K.R., Robertson, W.T., Ford, S., Watson, D., Fiscus, S., Harp, A.G., Hall, C.D. (2004). Highly active antiretroviral therapy improves neurocognitive functioning. Journal of Acquired Immune Deficiency Syndromes, 36(1), 562–566.Google Scholar
Robertson, K.R., Smurzynski, M., Parsons, T.D., Wu, K., Bosch, R.J., Wu, J., Ellis, R.J. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS, 21(14), 1915–1921.Google Scholar
Ryan, E.L., Morgello, S., Isaacs, K., Naseer, M., Gerits, P. (2004). Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology, 62(6), 957–962.CrossRefGoogle ScholarPubMed
Sacktor, N., McDermott, M.P., Marder, K., Schifitto, G., Selnes, O.A., McArthur, J.C., Epstein, L. (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. Journal of Neurovirology, 8(2), 136–142.Google Scholar
Sherman, K.E., Rouster, S.D., Chung, R.T., Rajicic, N. (2002). Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clinical Infectious Diseases, 34(6), 831–837.Google Scholar
Stern, R.A., Arruda, J.E., Somerville, J.A., Cohen, R.A., Boland, R.J., Stein, M.D., Martin, E.M. (1998). Neurobehavioral functioning in asymptomatic HIV-1 infected women. Journal of the International Neuropsychological Society, 4(2), 172–178.CrossRefGoogle ScholarPubMed
Stoff, D.M. (2004). Mental health research in HIV/AIDS and aging: Problems and prospects. AIDS, 18(Suppl. 1), S3–S10.CrossRefGoogle Scholar
Tarter, R.E., Hegedus, A.M., Van Thiel, D.H., Schade, R.R., Gavaler, J.S., Starzl, T.E. (1984). Nonalcoholic cirrhosis associated with neuropsychological dysfunction in the absence of overt evidence of hepatic encephalopathy. Gastroenterology, 86(6), 1421–1427.CrossRefGoogle ScholarPubMed
Thompson, P.M., Dutton, R.A., Hayashi, K.M., Toga, A.W., Lopez, O.L., Aizenstein, H.J., Becker, J.T. (2005). Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 15647–15652.Google Scholar
Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M.F., Visco-Comandini, U., Narciso, P. (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: Prevalence and risk factors. Journal of Acquired Immune Deficiency Syndromes, 45(2), 174–182.Google Scholar
Tozzi, V., Balestra, P., Lorenzini, P., Bellagamba, R., Galgani, S., Corpolongo, A., Narciso, P. (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort. Journal of Neurovirology, 11(3), 265–273.Google Scholar
Valcour, V.G., Shikuma, C.M., Watters, M.R., Sacktor, N.C. (2004). Cognitive impairment in older HIV-1-seropositive individuals: Prevalence and potential mechanisms. AIDS, 18(Suppl. 1), S79–S86.Google Scholar
Valcour, V.G., Yee, P., Williams, A.E., Shiramizu, B., Watters, M., Selnes, O., Sacktor, N. (2006). Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort. Journal of Neurovirology, 12(5), 387–391.Google Scholar
van Gorp, W.G., Wilkins, J.N., Hinkin, C.H., Moore, L.H., Hull, J., Horner, M.D., Plotkin, D. (1999). Declarative and procedural memory functioning in abstinent cocaine abusers. Archives of General Psychiatry, 56(1), 85–89.Google Scholar
Weber, R., Sabin, C.A., Friis-Moller, N., Reiss, P., El-Sadr, W.M., Kirk, O., Lundgren, J.D. (2006). Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study. Archives of Internal Medicine, 166(15), 1632–1641.Google Scholar
Wechsler, D. (1997). Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio, TX: The Psychological Corporation.Google Scholar
Weissenborn, K., Krause, J., Bokemeyer, M., Hecker, H., Schuler, A., Ennen, J.C., Boker, K.W. (2004). Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. Journal of Hepatology, 41(5), 845–851.CrossRefGoogle ScholarPubMed
Wilkinson, J., Radkowski, M., Laskus, T. (2009). Hepatitis C virus neuroinvasion: Identification of infected cells. Journal of Virology, 83(3), 1312–1319.Google Scholar
Woods, S.P., Moore, D.J., Weber, E., Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19(2), 152–168.Google Scholar